Gracell Biotechnologies Inc (DELISTED) (GRCL:DL)
10.25
0.00 (0.00%)
USD |
NASDAQ |
Feb 22, 16:00
Gracell Biotechnologies Cash and Short Term Investments (Quarterly): 234.08M for Sept. 30, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 234.08M |
| June 30, 2023 | 163.78M |
| March 31, 2023 | 185.60M |
| December 31, 2022 | 211.36M |
| September 30, 2022 | 228.69M |
| June 30, 2022 | 254.76M |
| March 31, 2022 | 266.56M |
| Date | Value |
|---|---|
| December 31, 2021 | 287.51M |
| September 30, 2021 | 302.48M |
| June 30, 2021 | 317.65M |
| March 31, 2021 | 329.60M |
| December 31, 2020 | 118.32M |
| September 30, 2020 | 26.00M |
| December 31, 2019 | 45.20M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
26.00M
Minimum
Sep 2020
329.60M
Maximum
Mar 2021
212.26M
Average
231.38M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| RayzeBio inc (DELISTED) | 540.17M |
| Zai Lab Ltd | 630.05M |
| WuXi Biologics (Cayman) Inc | 1.586B |
| Axonics Inc | 343.41M |
| I-MAB | 207.49M |